128 results
Page 4 of 7
8-K
EX-99.1
ymd41qjnbk bpq
11 Feb 20
FibroGen Announces U.S. FDA Acceptance of New Drug Application for Roxadustat for the Treatment of Anemia of Chronic Kidney Disease
5:16pm
8-K
EX-99.1
yga8nt250jasj5tbp7u
30 Jan 20
Astellas Submits Supplemental New Drug Application for Approval of
4:40pm
8-K
EX-99.1
1o560gqclieb7
13 Jan 20
Regulation FD Disclosure
9:01am
8-K
EX-99.1
znfptoi4
6 Jan 20
Fibrogen Names Enrique Conterno As Chief Executive Officer
5:23pm
8-K
EX-99.1
s6mkj7wnq18l33ios
23 Dec 19
Fibrogen Submits New Drug Application to the U.S. Fda for Roxadustat In Patients with Anemia of Chronic Kidney Disease
9:06am
8-K
EX-99.1
nykjngdt96nmlhx2clfy
2 Dec 19
FibroGen Announces Roxadustat Inclusion in China’s National Reimbursement Drug List
7:10am
8-K
EX-99.2
oykqm l3mqp9n7nmnhve
12 Nov 19
FibroGen Reports Third Quarter 2019 Financial Results
8:16am
8-K
EX-99.1
hfq4fm49jiz
12 Nov 19
FibroGen Reports Third Quarter 2019 Financial Results
8:16am
8-K
EX-99.1
8ghro21ry ne77hx
8 Nov 19
Regulation FD Disclosure
2:05pm
8-K
EX-99.1
0lsjlx0m4omiov90vr5
8 Nov 19
FibroGen Announces Positive Phase 3 Pooled Roxadustat Safety and Efficacy Results for Treatment of Anemia in Chronic Kidney Disease
2:00pm
8-K
EX-99.1
y8hhcfx 4i6k9ibwjzx
11 Oct 19
Regulation FD Disclosure
11:49am
8-K
EX-99.1
zxd7oy7 2xi
26 Sep 19
FibroGen Announces Initiation of Phase 2 Clinical Trial of Roxadustat for the Treatment
9:01am
8-K
EX-99.1
7f2 42ejmf89uk
20 Sep 19
Roxadustat Approved in Japan for the Treatment of Anemia Associated with Chronic Kidney Disease in Dialysis Patients
9:00am
8-K
EX-99.1
nuw qqguhv9w97
26 Aug 19
Departure of Directors or Certain Officers
9:04am
8-K
EX-99.1
yth36ghbgzw2md8
21 Aug 19
Roxadustat Approved In China for Treatment of Anemia In Chronic Kidney Disease Patients Not Receiving Dialysis
4:39pm
8-K
EX-99.1
eiyam9v
8 Aug 19
Fibrogen Reports Second Quarter 2019 Financial Results
4:15pm
8-K
EX-99.1
3tjkngy7tc02ej6mfa8
24 Jul 19
Other Events
9:46pm
8-K
EX-99.2
qtjg u38fbd7d5h
24 Jul 19
Other Events
9:46pm